75 related articles for article (PubMed ID: 20580551)
1. Synthesis and pharmacological evaluation of 1,1,3-substituted urea derivatives as potent TNF-alpha production inhibitors.
Enomoto H; Sawa A; Suhara H; Yamamoto N; Inoue H; Setoguchi C; Tsuji F; Okamoto M; Sasabuchi Y; Horiuchi M; Ban M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4479-82. PubMed ID: 20580551
[TBL] [Abstract][Full Text] [Related]
2. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
Murai M; Tsuji F; Nose M; Seki I; Oki K; Setoguchi C; Suhara H; Sasano M; Aono H
Eur J Pharmacol; 2008 Jul; 588(2-3):309-15. PubMed ID: 18508045
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents.
Tsuji F; Murai M; Oki K; Seki I; Ueda K; Inoue H; Nagelkerken L; Sasano M; Aono H
Eur J Pharmacol; 2010 Feb; 627(1-3):332-9. PubMed ID: 19878665
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2.
Nakao A; Ohkawa N; Nagasaki T; Kagari T; Doi H; Shimozato T; Ushiyama S; Aoki K
Bioorg Med Chem Lett; 2010 Apr; 20(8):2435-7. PubMed ID: 20346666
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR studies for the inhibition of TNF-alpha production. Part 2. 2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-substituted-1-isoindolinone derivatives.
Park JS; Moon SC; Baik KU; Cho JY; Yoo ES; Byun YS; Park MH
Arch Pharm Res; 2002 Apr; 25(2):137-42. PubMed ID: 12009025
[TBL] [Abstract][Full Text] [Related]
6. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).
Ghiron C; Haydar SN; Aschmies S; Bothmann H; Castaldo C; Cocconcelli G; Comery TA; Di L; Dunlop J; Lock T; Kramer A; Kowal D; Jow F; Grauer S; Harrison B; La Rosa S; Maccari L; Marquis KL; Micco I; Nencini A; Quinn J; Robichaud AJ; Roncarati R; Scali C; Terstappen GC; Turlizzi E; Valacchi M; Varrone M; Zanaletti R; Zanelli U
J Med Chem; 2010 Jun; 53(11):4379-89. PubMed ID: 20465311
[TBL] [Abstract][Full Text] [Related]
7. The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones.
Laufersweiler MJ; Brugel TA; Clark MP; Golebiowski A; Bookland RG; Laughlin SK; Sabat MP; Townes JA; VanRens JC; De B; Hsieh LC; Heitmeyer SA; Juergens K; Brown KK; Mekel MJ; Walter RL; Janusz MJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4267-72. PubMed ID: 15261284
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha.
Hilmy KM
Arch Pharm (Weinheim); 2004 Jan; 337(1):15-9. PubMed ID: 14760623
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.
Kim YJ; Ryu JH; Cheon YJ; Lim HJ; Jeon R
Bioorg Med Chem Lett; 2007 Jun; 17(12):3317-21. PubMed ID: 17467989
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
Zheng QZ; Cheng K; Zhang XM; Liu K; Jiao QC; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3207-12. PubMed ID: 20381216
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
13. Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
Cottam HB; Shih H; Tehrani LR; Wasson DB; Carson DA
J Med Chem; 1996 Jan; 39(1):2-9. PubMed ID: 8568809
[TBL] [Abstract][Full Text] [Related]
14. A small compound that inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production.
Kim JI; Lee HY; Park KS; Lee T; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2006 Sep; 347(3):797-802. PubMed ID: 16842752
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
16. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
Ke S; Li Z; Qian X
Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Apr; 27(4):443-7. PubMed ID: 17414429
[TBL] [Abstract][Full Text] [Related]
18. Imidazo[1,2-a]pyridine derivatives as inhibitors of TNF-alpha expression in T cells.
Rether J; Erkel G; Anke T; Bajtner J; Sterner O
Bioorg Med Chem; 2008 Feb; 16(3):1236-41. PubMed ID: 18035545
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.
Maitraie D; Hung CF; Tu HY; Liou YT; Wei BL; Yang SC; Wang JP; Lin CN
Bioorg Med Chem; 2009 Apr; 17(7):2785-92. PubMed ID: 19278854
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
Vendeville S; Nilsson M; de Kock H; Lin TI; Antonov D; Classon B; Ayesa S; Ivanov V; Johansson PO; Kahnberg P; Eneroth A; Wikstrom K; Vrang L; Edlund M; Lindström S; Van de Vreken W; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Van Dooren M; Kindermans N; Surleraux D; Wigerinck P; Rosenquist A; Samuelsson B; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2008 Dec; 18(23):6189-93. PubMed ID: 18954982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
